Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Pedro Lichtinger Net Worth & Insider Trades

Pedro Lichtinger - Director, Gemphire Therapeutics Inc

As of July 26, 2019

What is Pedro Lichtinger's Net Worth?

The current estimated net worth of Gemphire Therapeutics Inc's Director, Pedro Lichtinger, is estimated to be about $2.14M . Pedro Lichtinger owns about 59,833 units of Gemphire Therapeutics Inc common stock. In the last 3 years at Gemphire Therapeutics Inc, Pedro Lichtinger has sold an estimated value of $0 worth.

What is Pedro Lichtinger's Past Insider Trading?

Pedro Lichtinger's largest purchase order was 49,274 units , worth over $363.37K on August 12, 2016. In total, Pedro Lichtinger has made about 5 transactions over 3 years of their time at Gemphire Therapeutics Inc. Pedro Lichtinger usually trades in August, with the busiest year in 2016. The most recent transaction was a purchase order of 10,559 units , worth over $99.99K on March 14, 2017.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PEDRO LICHTINGER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Pedro Lichtinger's' Mailing Address?

  • Mailing address is 1301 Harbor Bay Parkway Alameda CA 94502 CA

What are Gemphire Therapeutics Inc's Past Insider Trades?

Gemphire Therapeutics Inc's most recent insider trade came on February 12, 2018 by Seth Reno who bought 14,286 units worth $100K . In the last 2 years, insiders at Gemphire Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in August, with the busiest year in 2016. The most active traders at the company are Phd Steven Gullans, President & CEO,  Andy Sassine, Director,  and Jeffrey Mathiesen, Chief Financial Officer .

Gemphire Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...